Universal-Beteiligungs- und Servicegesellschaft
AKTS icon

Universal-Beteiligungs- und Servicegesellschaft’s Aktis Oncology AKTS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,185
Closed -$254K – 2215
2026
Q1 		$254K Buy
+14,185
New +$275K ﹤0.01% 1920

Other funds holding AKTS

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's AKTS Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Aktis Oncology (AKTS) in Q2 2026, closing a stake of 14,185 shares — an estimated $254K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in AKTS in Q1 2026 and held it in 1 quarter. The position peaked at $254K in Q1 2026. 113 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Aktis Oncology position as of Q2 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 14,185 Aktis Oncology shares in Q2 2026, an estimated $254K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Aktis Oncology in Q1 2026 and held it in 1 quarter.
  • Universal-Beteiligungs- und Servicegesellschaft's Aktis Oncology position peaked at $254K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.